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1. To examine the proportion of patients travelling more than 45 minutes to the Study Centre to 
compare against NRAG standards.
2. To explore the distances travelled by patients to the Study Centre.
3. To examine the number of patients attending the Study Centre in terms of diagnosis and 
treatment intent, to compare against NHS England proposals.
Data was extracted from the patient information management system for all patients who attended 
the Study Centre for treatment preparation from 1st April 2016 to 31st March 2017 (2016/2017).   
Only entries with postcodes from inside the Study Centre’s catchment area were included; the area 
was divided into 4 main areas based on the first two letters of the postcode (BB, FY, LA and PR).  
Travel times and distances for each postcode entry to the Study Centre were calculated using 
Google Maps.4 The journey with the shortest distance was always chosen where more than one 
option was given. Journeys were estimated for off-peak travel and with private transport.
The National Radiotherapy Advisory Group (NRAG) recommended a one-way journey for treatment 
should not exceed 45 minutes.1 Travel time can reduce treatment uptake.2 This evaluation 
compares travel times across the catchment area of the Rosemere Cancer Centre, Preston.  At the 
Study Centre, radiotherapy is delivered on one site at an acute hospital, and patients attend from a 
wide geographical catchment area which covers both rural and suburban areas. 
The work has also looked at patient attendance in terms of diagnosis and treatment intent, to allow 
comparison with current proposals for modernising radiotherapy networks by NHS England.3  These 
proposals support the delivery of care close to a patient’s home where clinically appropriate.3
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The majority of patients (87.2%) attending the Study Centre are served well in terms of the 
NRAG 45-minute recommendation.1 However, journeys were estimated for off-peak travel 
using private transport.  Most patient groups currently treated at the Study Centre would be 
unaffected in terms of travel time, if the plans to modernise radiotherapy services were 
implemented.3 Overall, this study highlights where there is scope for improving and developing 
clinical services in the future in terms of patient experience.  Future work would look for any 
time trends by analysing earlier years in the development of the Study Centre.
In 2016/2017, there were 4012 attendances for 
treatment preparation eligible for analysis.  Figure 1 
shows the one-way travel time average for each area 
compared to the 45-minute recommendation.  Figure 
2 shows the percentage of patients travelling 45 
minutes or less, and more than 45 minutes.
The average distance travelled to the Study Centre 
was 20.1 miles (s = 14.8 miles).  Patients in the ‘LA’ 
postcode area had the highest average travel 
distance of 41.3 miles (s = 17.6); but made up the 
smallest proportion of patients by area (19%).
The Study Centre met the required patient throughput 
for all common and all but one of the less common 
cancers, as described by NHS England proposals.3
The number of patients being treated for rare cancer 
types were lower than the recommended throughput.3
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